New Delhi: Eli Lilly and Company (Lilly) has announced the appointment of Winselow Tucker as the President and General Manager for Lilly India, effective immediately. In his new role, Winselow will oversee all of Lilly’s operations in India, including the Lilly India commercial organization and the Lilly Capability Centre India (LCCI) in Bengaluru and Hyderabad.
Commenting on the appointment, Ilya Yuffa, Executive Vice President and President of Lilly International, said, “This key leadership move brings all our operations under a ‘One India’ strategic framework, reinforcing our unified strategy and deepened commitment to driving growth and innovation in the country. Winselow’s extensive experience and strategic vision will be pivotal in positioning Lilly for long-term success in India.”
Expressing enthusiasm about his new role, Winselow Tucker stated, “I am excited to join Lilly India at such a significant time as we continue to expand and strengthen our presence in one of the world’s fastest-growing economies. I look forward to working with our talented teams in India to drive innovation and deliver world-class Lilly medicines that address the unmet medical needs of patients in the country.”
Since joining Lilly in 2022, Winselow has served as Group Vice President and Chief Commercial Officer of Lilly Oncology, leading commercialization strategies for the Oncology business across global markets. His prior experience includes senior leadership roles at Bristol Myers Squibb (BMS), Celgene, and Novartis. He holds a bachelor’s degree in business administration from Howard University and an MBA from Indiana University.
